Physician profile
Brandon L Smith
NPI 1871880369
$3,632.81
in general payments reported to CMS, 2019-2025
16 companies · $61.56 in 2025
The $61.56 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $240 · 2021: $65.80 · 2022: $612 · 2023: $56.32 · 2024: $2,233 · 2025: $61.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334 · Entertainment: $16.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,334.48 |
| Entertainment | $16.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,057.18 | 2024 | Optilight |
| Johnson & Johnson Surgical Vision, INC. | $544.65 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $357.67 | 2019-2021 | |
| Alcon Vision LLC | $163.62 | 2019-2022 | |
| Biotissue Holdings INC. | $120.67 | 2024 | |
| Coopervision INC. | $90.65 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $75.66 | 2022-2024 | Infuse |
| Johnson & Johnson Vision Care, INC. | $72.16 | 2020-2025 | |
| Lkc Technologies, INC. | $30.62 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $24.81 | 2025 | Xdemvy |
| Abbvie INC. | $20.16 | 2023 | Lumigan, Alphagan P |
| Allergan, INC. | $16.88 | 2022 | |
| Optos, INC. | $16.81 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Quidel Corporation | $13.88 | 2019 | |
| Dompe US, INC. | $13.77 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.